V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220014928 | 220009543 | 1.64 | 20.9 | Disease modification (D) | 2014-02-27 | 2014-02-27 | CAPECITABINE + OXALIPLATIN | 2 | N | 220036269 | UKALL2011 |
| 220014929 | 220009543 | null | 72.5 | Palliative (P) | 2015-09-20 | 2015-11-10 | ALL UKALL2011 Maintenance A2 | N | N | 220036269 | FIGARO TRIAL |
| 220014930 | 220019994 | 1.73 | 60 | Not known (9) | 2017-07-19 | 2017-07-19 | CYCLET | N | N | 220036278 | IRINOTECAN |
| 220014932 | 220015064 | null | null | Curative (C) | 2016-01-11 | 2016-01-11 | CISPLATIN + RT | null | N | 220036286 | MELPHALAN |
| 220014933 | 220009546 | null | 81.3 | Palliative (P) | 2015-02-14 | 2015-03-05 | Capecitabine (21days) + Carboplatin | N | N | 220036297 | VINCRISTINE |
| 220014934 | 220009548 | 1.56 | 73.05 | Curative (C) | 2017-09-08 | 2017-09-13 | FLUDARABINE | null | null | 220036310 | CARBOPLATIN |
| 220014935 | 220009549 | 1.63 | null | Curative (C) | 2017-02-02 | 2017-02-02 | CTD | 02 | N | 220036312 | MELPHALAN |
| 220014936 | 220009551 | null | null | Disease modification (D) | 2017-12-25 | 2018-01-22 | Lomustine | N | N | 220036313 | IMATINIB + HYDROXYCARBAMIDE |
| 220014938 | 220009554 | 1.86 | 87.4 | Palliative (P) | 2014-04-06 | 2014-04-12 | GEMCITABINE | N | N | 220036331 | CLADRIBINE |
| 220014939 | 220009556 | 1.52 | 55 | Palliative (P) | 2016-12-03 | 2017-05-06 | PERM Trial | 3 | N | 220036334 | IPILIMUMAB |
| 220014940 | 220018216 | null | null | Disease modification (D) | null | 2016-05-23 | Carboplatin AUC 2 - 5 | N | N | 220036338 | FLA |
| 220014941 | 220009561 | 1.72 | 89.9 | Palliative (P) | 2017-05-07 | 2017-05-30 | Bevacizumab 5mg/kg | N | N | 220036358 | CISPLATIN + RT |
| 220014942 | 220009562 | null | null | Palliative (P) | 2014-03-23 | 2014-06-23 | Alemtuz+Cyclophos+Fludara Allo | 2 | null | 220036369 | CARBOPLATIN |
| 220014943 | 220009563 | null | null | null | 2018-01-19 | 2018-01-19 | Sunitinib | N | N | 220036370 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 220014944 | 220015069 | 0 | 78 | Curative (C) | 2015-01-16 | 2015-02-04 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 220036377 | CAPECITABINE |
| 220014945 | 220015069 | null | 83 | Curative (C) | 2015-10-24 | 2015-11-27 | FIGARO TRIAL | N | null | 220036377 | CVD |
| 220014946 | 220019995 | 1.62 | 62.5 | Not known (9) | 2018-11-09 | 2018-12-10 | Sorafenib | N | N | 220036389 | ERLOTINIB |
| 220014947 | 220009565 | 1.58 | 69.6 | Palliative (P) | null | 2013-09-21 | FIGARO TRIAL | N | N | 220036395 | TEMOZOLOMIDE |
| 220014948 | 220009566 | 1.75 | 76.7 | null | 2017-11-13 | 2017-11-13 | PEMBROLIZUMAB | N | N | 220036395 | PEMBROLIZUMAB |
| 220014949 | 220009567 | 1.78 | null | null | null | 2018-01-30 | FLUDARABINE | null | N | 220036408 | CARBOPLATIN + CETUXIMAB + FU |
| 220014950 | 220009569 | 1.78 | 82 | Palliative (P) | 2017-05-11 | 2017-05-13 | Ipilimumab | 2 | N | 220036412 | BUSULPHAN |
| 220014951 | 220009571 | 1.64 | 84.8 | null | 2016-11-28 | 2016-12-04 | Arsenic Triox + Tretinoin Ind W1-4 | N | N | 220036412 | TRASTUZUMAB |
| 220014952 | 220009572 | 1.57 | 60 | Palliative (P) | 2013-03-29 | 2013-04-16 | Arsenic trioxide | 02 | N | 220036413 | UKALL 2011 |
| 220014953 | 220009572 | null | null | Curative (C) | 2015-12-04 | 2015-12-04 | Cape+Cisplatin+Trastuzumab Main | N | N | 220036413 | CHLVPP |
| 220014954 | 220009573 | 1.71 | 53.6 | Curative (C) | 2014-12-25 | 2014-12-26 | Lenalidomide 25mg (Cycle 1 to 25) | N | N | 220036423 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE |
| 220014955 | 220009574 | 1.53 | 56.9 | Curative (C) | 2013-04-16 | 2013-04-16 | Dacarbazine | null | N | 220036427 | ABVD |
| 220014956 | 220015073 | 1.91 | 108 | Palliative (P) | 2016-07-28 | 2016-08-07 | TRASTUZUMAB | 02 | N | 220036432 | PEMBROLIZUMAB |
| 220014957 | 220009582 | 1.65 | 0 | Not known (9) | 2017-10-15 | 2017-10-15 | CYTARABINE + MITOXANTRONE | N | N | 220036432 | FLUOROURACIL + MITOMYCIN |
| 220014958 | 220009583 | 1.3 | null | Palliative (P) | 2016-01-17 | 2015-10-04 | LEAM | N | null | 220036439 | SORAFENIB |
| 220014959 | 220009583 | 1.85 | 73 | Curative (C) | 2016-10-15 | 2016-11-08 | Cetuximab 14 day | N | N | 220036439 | CISPLATIN + FLUOROURACIL |
| 220014960 | 220009584 | 0 | null | Palliative (P) | 2018-03-31 | 2018-04-04 | Gemcitabine + Capecitabine | 2 | N | 220036441 | CAPECITABINE + IRINOTECAN |
| 220014961 | 220009585 | 1.87 | 102.7 | Palliative (P) | 2016-11-24 | 2016-11-24 | Temozolomide 150mg/m2 | 02 | N | 220036443 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE |
| 220014962 | 220009586 | 1.68 | 74.8 | Curative (C) | 2015-03-30 | 2015-04-07 | MidAC | 1 | N | 220036446 | MIDAC |
| 220014963 | 220009586 | null | 61.8 | null | 2014-03-19 | 2014-03-19 | FLA | N | N | 220036446 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE |
| 220014964 | 220009586 | 1.66 | 23.7 | Palliative (P) | 2017-08-08 | 2017-08-15 | GEMCITABINE | N | N | 220036446 | ROMAZA TRIAL |
| 220014965 | 220009587 | 1.66 | 79.6 | Palliative (P) | 2016-05-07 | 2016-05-08 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 220036453 | RAVVA TRIAL |
| 220014966 | 220009589 | 0 | 61 | Palliative (P) | 2017-05-17 | 2017-05-18 | EOX | N | N | 220036461 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 220014967 | 220009590 | 1.51 | 88.65 | null | 2014-10-02 | 2014-11-13 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 220036467 | PACKER INDUCTION VINCRISTINE + RT |
| 220014968 | 220009590 | 1.62 | 67.3 | Palliative (P) | null | 2013-10-14 | Midostaurin | 2 | N | 220036467 | EVEROLIMUS |
| 220014969 | 220009591 | 1.8 | 94.2 | Palliative (P) | null | 2013-06-03 | Sorafenib | N | N | 220036472 | IPILIMUMAB |
| 220014970 | 220015081 | 1.72 | 57.5 | Palliative (P) | null | 2013-08-26 | FLUDARABINE | null | null | 220036472 | OSIMERTINIB |
| 220014971 | 220009592 | 1.52 | 54.7 | Palliative (P) | 2017-10-18 | 2018-03-24 | CARBOPLATIN + RT | N | N | 220036485 | CARBOPLATIN + LIPOSOMAL DOX |
| 220014972 | 220018224 | 1.76 | 73.8 | Curative (C) | null | 2013-11-06 | Etoposide oral | 2 | N | 220036486 | ARSENIC TRIOXIDE + ATRA |
| 220014973 | 220009593 | null | 86 | Palliative (P) | null | 2016-03-20 | CYTARABINE + FLUDARABINE + IDARUBICIN | N | N | 220036517 | CARBOPLATIN |
| 220014974 | 220009594 | 1.86 | 96.7 | Palliative (P) | 2017-01-31 | 2017-01-31 | INTERFERON | 2 | N | 220036524 | EOX |
| 220014975 | 220018226 | null | null | Palliative (P) | 2014-05-12 | 2014-09-21 | GEMCITABINE | N | null | 220036525 | CHOP |
| 220014976 | 220009597 | 1.68 | 58 | null | 2017-05-26 | 2017-05-26 | EC | N | N | 220036533 | FCR |
| 220014977 | 220009598 | 1.81 | 76 | Palliative (P) | 2016-04-04 | 2016-07-01 | Carboplatin AUC 2 - 5 | N | N | 220036534 | LIPOSOMAL DOXORUBICIN |
| 220014978 | 220009598 | null | null | Palliative (P) | 2015-05-07 | 2015-05-11 | MidAC | N | N | 220036534 | ALEMTUZUMAB + CYCLO + FLUDARABINE |
| 220014979 | 220009599 | 1.73 | 108 | Curative (C) | 2015-05-22 | 2015-05-27 | FLUOROURACIL + MITOMYCIN | N | Y | 220036539 | CHOP R |